TP53 and neoplasm: This hypothesis is corroborated by other evidences demonstrating that stathmin is necessary for the survival of p53-null cells [37] and is a direct target of PI3K and Ras-MAPK [4]–[9], two pathways frequently linked to tumor onset in humans.